Molecular and histological evidence indicates that BC can be divided into 3 subtypes: BC expressing human epidermal receptor 2 (HER2+), hormone receptor-positive (ER+) or progesterone receptor positive (PR+) BC, and triple-negative BC (ER-, PR-, HER2-) [4, 5]. Here, ERBB2 is linked to breast cancer.